These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3905315)
1. Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth. Russell DH Drug Metab Rev; 1985; 16(1-2):1-88. PubMed ID: 3905315 [No Abstract] [Full Text] [Related]
2. Ornithine decarboxylase activity is critical for cell transformation. Auvinen M; Paasinen A; Andersson LC; Hölttä E Nature; 1992 Nov; 360(6402):355-8. PubMed ID: 1280331 [TBL] [Abstract][Full Text] [Related]
4. Retinol inhibition of ornithine decarboxylase induction and G1 progression in Chinese hamster ovary cells. Haddox MK; Scott KF; Russell DH Cancer Res; 1979 Dec; 39(12):4930-8. PubMed ID: 498118 [No Abstract] [Full Text] [Related]
12. A new perspective on ornithine decarboxylase regulation: prevention of polyamine toxicity is the overriding theme. Morris DR J Cell Biochem; 1991 Jun; 46(2):102-5. PubMed ID: 1918176 [TBL] [Abstract][Full Text] [Related]
13. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines. Hurta RA; Wright JA J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612 [TBL] [Abstract][Full Text] [Related]
14. Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. Hibshoosh H; Johnson M; Weinstein IB Oncogene; 1991 May; 6(5):739-43. PubMed ID: 1711188 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931 [TBL] [Abstract][Full Text] [Related]
16. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1). Hurta RA; Lee J; Voskas D J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396 [TBL] [Abstract][Full Text] [Related]
17. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Megosh L; Gilmour SK; Rosson D; Soler AP; Blessing M; Sawicki JA; O'Brien TG Cancer Res; 1995 Oct; 55(19):4205-9. PubMed ID: 7671221 [TBL] [Abstract][Full Text] [Related]
18. The effect of testosterone on the half-life of ornithine decarboxylase-mRNA in mouse kidney. Laitinen SI; Laitinen PH; Pajunen AE Biochem Int; 1984 Jul; 9(1):45-50. PubMed ID: 6477638 [TBL] [Abstract][Full Text] [Related]
19. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation. Keren-Paz A; Bercovich Z; Kahana C Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267 [TBL] [Abstract][Full Text] [Related]
20. alpha-Difluoromethylornithine, a polyamine inhibitor: its potential role in controlling hair growth and in cancer treatment and chemo-prevention. Smith KJ; Skelton H Int J Dermatol; 2006 Apr; 45(4):337-44. PubMed ID: 16650154 [No Abstract] [Full Text] [Related] [Next] [New Search]